EP3115454 - NOVEL RNA SEQUENCE HAVING ANTI-TUMOUR ACTIVITY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.12.2020 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 10.01.2020 | ||
Former | Grant of patent is intended Status updated on 28.08.2019 | ||
Former | Examination is in progress Status updated on 12.10.2018 | ||
Former | Request for examination was made Status updated on 09.12.2016 | ||
Former | The international publication has been made Status updated on 04.11.2016 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Yamamoto, Hirofumi Graduate School of Medicine Department of Gastroenterological Surgery E-2 2-2 Yamadaoka Suita-shi, Osaka 565-0871 / JP | For all designated states Mori, Masaki Graduate School of Medicine Department of Gastroenterological Surgery E-2 2-2 Yamadaoka Suita-shi, Osaka 565-0871 / JP | [2017/02] | Inventor(s) | 01 /
YAMAMOTO, Hirofumi c/o OSAKA UNIVERSITY, Graduate School of Medicine Department of Gastroenterological Surgery E-2, 2-2, Yamadaoka Suita-shi, Osaka 565-0871 / JP | 02 /
MORI, Masaki c/o OSAKA UNIVERSITY,Graduate School of Medicine Department of Gastroenterological Surgery E-2, 2-2, Yamadaoka Suita-shi, Osaka 565-0871 / JP | 03 /
DOKI, Yuichiro c/o OSAKA UNIVERSITY 1-1 Yamadaoka Suita-shi Osaka 565-0871 / JP | [2020/07] |
Former [2017/02] | 01 /
YAMAMOTO, Hirofumi Graduate School of Medicine Department of Gastroenterological Surgery E-2 2 2 Yamadaoka Suita-shi Osaka 565-0871 / JP | ||
02 /
MORI, Masaki Graduate School of Medicine Department of Gastroenterological Surgery E-2 2 2 Yamadaoka Suita-shi Osaka 565-0871 / JP | |||
03 /
DOKI, Yuichiro c/o OSAKA UNIVERSITY 1-1 Yamadaoka Suita-shi Osaka 565-0871 / JP | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2017/02] | Application number, filing date | 15757718.0 | 04.03.2015 | [2017/02] | WO2015JP56352 | Priority number, date | JP20140041769 | 04.03.2014 Original published format: JP 2014041769 | [2017/02] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015133521 | Date: | 11.09.2015 | Language: | JA | [2015/36] | Type: | A1 Application with search report | No.: | EP3115454 | Date: | 11.01.2017 | Language: | EN | [2017/02] | Type: | B1 Patent specification | No.: | EP3115454 | Date: | 12.02.2020 | Language: | EN | [2020/07] | Search report(s) | International search report - published on: | JP | 11.09.2015 | (Supplementary) European search report - dispatched on: | EP | 17.07.2017 | Classification | IPC: | C12N15/00, A61K9/14, A61K31/7088, A61K47/02, A61K48/00, A61P35/00, C12N15/09, A61K9/51, A61K9/00, C12N15/113 | [2017/33] | CPC: |
C12N15/113 (EP,US);
A61K47/02 (EP,US);
A61K9/0019 (EP,US);
A61K9/5115 (EP,US);
A61P1/00 (EP);
A61P35/00 (EP);
|
Former IPC [2017/02] | C12N15/00, A61K9/14, A61K31/7088, A61K47/02, A61K48/00, A61P35/00, C12N15/09 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/02] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | NEUARTIGE RNA-SEQUENZ MIT ANTITUMORWIRKUNG | [2017/02] | English: | NOVEL RNA SEQUENCE HAVING ANTI-TUMOUR ACTIVITY | [2017/02] | French: | NOUVELLE SÉQUENCE D'ARN POSSÉDANT UNE ACTIVITÉ ANTI-TUMORALE | [2017/02] | Entry into regional phase | 28.09.2016 | Translation filed | 28.09.2016 | National basic fee paid | 28.09.2016 | Search fee paid | 28.09.2016 | Designation fee(s) paid | 28.09.2016 | Examination fee paid | Examination procedure | 28.09.2016 | Examination requested [2017/02] | 28.09.2016 | Date on which the examining division has become responsible | 13.02.2018 | Amendment by applicant (claims and/or description) | 12.10.2018 | Despatch of a communication from the examining division (Time limit: M04) | 13.02.2019 | Reply to a communication from the examining division | 29.08.2019 | Communication of intention to grant the patent | 20.12.2019 | Fee for grant paid | 20.12.2019 | Fee for publishing/printing paid | 20.12.2019 | Receipt of the translation of the claim(s) | Opposition(s) | 13.11.2020 | No opposition filed within time limit [2021/03] | Fees paid | Renewal fee | 13.03.2017 | Renewal fee patent year 03 | 21.03.2018 | Renewal fee patent year 04 | 15.03.2019 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 04.03.2015 | AL | 12.02.2020 | AT | 12.02.2020 | CY | 12.02.2020 | CZ | 12.02.2020 | DK | 12.02.2020 | EE | 12.02.2020 | ES | 12.02.2020 | FI | 12.02.2020 | HR | 12.02.2020 | IT | 12.02.2020 | LT | 12.02.2020 | LV | 12.02.2020 | MC | 12.02.2020 | MK | 12.02.2020 | MT | 12.02.2020 | NL | 12.02.2020 | PL | 12.02.2020 | RO | 12.02.2020 | RS | 12.02.2020 | SI | 12.02.2020 | SK | 12.02.2020 | SM | 12.02.2020 | TR | 12.02.2020 | IE | 04.03.2020 | LU | 04.03.2020 | BE | 31.03.2020 | BG | 12.05.2020 | NO | 12.05.2020 | GR | 13.05.2020 | IS | 12.06.2020 | PT | 05.07.2020 | [2022/31] |
Former [2022/30] | HU | 04.03.2015 | |
AL | 12.02.2020 | ||
AT | 12.02.2020 | ||
CY | 12.02.2020 | ||
CZ | 12.02.2020 | ||
DK | 12.02.2020 | ||
EE | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
IT | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
MC | 12.02.2020 | ||
MT | 12.02.2020 | ||
NL | 12.02.2020 | ||
PL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SI | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
TR | 12.02.2020 | ||
IE | 04.03.2020 | ||
LU | 04.03.2020 | ||
BE | 31.03.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2022/27] | HU | 04.03.2015 | |
AT | 12.02.2020 | ||
CY | 12.02.2020 | ||
CZ | 12.02.2020 | ||
DK | 12.02.2020 | ||
EE | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
IT | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
MC | 12.02.2020 | ||
MT | 12.02.2020 | ||
NL | 12.02.2020 | ||
PL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SI | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
TR | 12.02.2020 | ||
IE | 04.03.2020 | ||
LU | 04.03.2020 | ||
BE | 31.03.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2021/10] | AT | 12.02.2020 | |
CZ | 12.02.2020 | ||
DK | 12.02.2020 | ||
EE | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
IT | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
MC | 12.02.2020 | ||
NL | 12.02.2020 | ||
PL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SI | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
IE | 04.03.2020 | ||
LU | 04.03.2020 | ||
BE | 31.03.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2021/08] | CZ | 12.02.2020 | |
DK | 12.02.2020 | ||
EE | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
MC | 12.02.2020 | ||
NL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
IE | 04.03.2020 | ||
LU | 04.03.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2021/04] | CZ | 12.02.2020 | |
DK | 12.02.2020 | ||
EE | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
MC | 12.02.2020 | ||
NL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
LU | 04.03.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2020/52] | CZ | 12.02.2020 | |
DK | 12.02.2020 | ||
EE | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
MC | 12.02.2020 | ||
NL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2020/50] | CZ | 12.02.2020 | |
DK | 12.02.2020 | ||
EE | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
NL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2020/49] | CZ | 12.02.2020 | |
DK | 12.02.2020 | ||
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
NL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SK | 12.02.2020 | ||
SM | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2020/48] | DK | 12.02.2020 | |
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
NL | 12.02.2020 | ||
RO | 12.02.2020 | ||
RS | 12.02.2020 | ||
SM | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
PT | 05.07.2020 | ||
Former [2020/47] | DK | 12.02.2020 | |
ES | 12.02.2020 | ||
FI | 12.02.2020 | ||
HR | 12.02.2020 | ||
LT | 12.02.2020 | ||
LV | 12.02.2020 | ||
NL | 12.02.2020 | ||
RS | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
Former [2020/45] | FI | 12.02.2020 | |
HR | 12.02.2020 | ||
LV | 12.02.2020 | ||
NL | 12.02.2020 | ||
RS | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
Former [2020/40] | FI | 12.02.2020 | |
HR | 12.02.2020 | ||
LV | 12.02.2020 | ||
RS | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
IS | 12.06.2020 | ||
Former [2020/39] | FI | 12.02.2020 | |
HR | 12.02.2020 | ||
LV | 12.02.2020 | ||
RS | 12.02.2020 | ||
BG | 12.05.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
Former [2020/38] | FI | 12.02.2020 | |
HR | 12.02.2020 | ||
LV | 12.02.2020 | ||
RS | 12.02.2020 | ||
NO | 12.05.2020 | ||
GR | 13.05.2020 | ||
Former [2020/37] | FI | 12.02.2020 | |
HR | 12.02.2020 | ||
LV | 12.02.2020 | ||
RS | 12.02.2020 | ||
NO | 12.05.2020 | ||
Former [2020/35] | FI | 12.02.2020 | |
NO | 12.05.2020 | Documents cited: | Search | [Y]WO2011130464 (ABRAXIS BIOSCIENCE LLC [US], et al) [Y] 1-10 * paragraph [0104] * * paragraph [0175] * * claims 1-43 *; | [Y]US2012251619 (GUNARATNE PREETHI H [US]) [Y] 1-10 * paragraph [0016] - paragraph [0017] * * paragraph [0035] - paragraph [0036] *; | [Y] - HOSSAIN S ET AL, "Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 147, no. 1, ISSN 0168-3659, (20101001), pages 101 - 108, (20100708), XP027272150 [Y] 1-10 * the whole document, especially the abstract * | [Y] - GEERTRUI TAVERNIER ET AL, "mRNA as gene therapeutic: How to control protein expression", JOURNAL OF CONTROLLED RELEASE, (20110301), vol. 150, no. 3, doi:10.1016/j.jconrel.2010.10.020, ISSN 0168-3659, pages 238 - 247, XP055068617 [Y] 1-10 * right-hand column; page 242 * DOI: http://dx.doi.org/10.1016/j.jconrel.2010.10.020 | [YP] - "Abstract Book: Society of Surgical Oncology 69thAnnual Cancer Symposium", ANNALS OF SURGICAL ONCOLOGY, RAVEN PRESS, NEW YORK, NY, US, vol. 23, no. 1, doi:10.1245/S10434-015-5010-5, ISSN 1068-9265, (20160108), pages 1 - 195, (20160108), XP035897758 [YP] 1-10 * P100 * DOI: http://dx.doi.org/10.1245/s10434-015-5010-5 | [YP] - XIAN-JUN SUN ET AL, "MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin", CELLULAR PHYSIOLOGY AND BIOCHEMISTRY., CH, (20150911), vol. 37, no. 2, doi:10.1159/000430389, ISSN 1015-8987, pages 707 - 718, XP055386972 [YP] 1-10 * the whole document * DOI: http://dx.doi.org/10.1159/000430389 | International search | [Y]JP2006509838 (The Circle for the Promotion of Science and Engineering) [Y] 7* , & WO 2004/043495 A1 *; | [XY]WO2013109604 (ALNYLAM PHARMACEUTICALS INC [US]) [X] 1-6, 9-10 * , & US 2014/0363469 A * [Y] 5-7, 9; | [Y] - POUDYAL D. et al., "A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng", PLOS ONE, (20130000), vol. 8, no. 10, page e75034, XP055357961 [Y] 5-7, 9 DOI: http://dx.doi.org/10.1371/journal.pone.0075034 | [Y] - F ANG J. H. et al., "MicroRNA-29b Suppresses Tumor Angiogenesis, Invasion, and Metastasis by Regulating Matrix Metalloproteinase 2 Expression", Hepatology, (20110000), vol. 54, no. 5, ISSN 0270-9139, pages 1729 - 40, XP 055222863 [Y] 5-7, 9 |